Dopamine Transporter: Aging and Parkinson’s Disease

[1]  R. Bressan,et al.  Parkinson's disease and dopamine transporter neuroimaging: a critical review. , 2006, Sao Paulo medical journal = Revista paulista de medicina.

[2]  C. Marsden.  Dopamine: the rewarding years , 2006, British journal of pharmacology.

[3]  A. Ludolph,et al.  Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration , 2004, Journal of Neural Transmission.

[4]  Donald Grosset,et al.  Role of dopamine transporter imaging in routine clinical practice , 2003, Movement disorders : official journal of the Movement Disorder Society.

[5]  George R Uhl,et al.  Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism , 2003, Movement disorders : official journal of the Movement Disorder Society.

[6]  O. Hornykiewicz.  Dopamine miracle: From brain homogenate to dopamine replacement , 2002, Movement Disorders.

[7]  D. Mash,et al.  Dopamine transporter‐immunoreactive neurons decrease with age in the human substantia nigra , 1999, The Journal of comparative neurology.

[8]  M. Bannon,et al.  Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Mcgeer,et al.  Dopamine-acetylcholine-GABA neuronal linkages in the extrapyramidal and limbic systems. , 1977, Advances in biochemical psychopharmacology.